Canadian researchers recently conducted a telephone survey to evaluate patients’ understanding of the importance and adherence to various lifestyle and Age-Related Eye Disease Study (AREDS) supplement recommendations. Tobacco smoking was one of the lifestyle choices looked at. Of the 92 patients contacted, 98% knew about the AREDS formula, with 74% agreeing that high doses of [Read More]
Category: Latest News
Vision Loss and Social Security Disability
Decreased vision leads to detrimental, life-altering complications, which often include loss of employment and increased difficulty carrying out everyday activities. If vision loss has negatively impacted your life, you may qualify for Social Security disability payments. There are two ways to file. If you have severe vision loss in both eyes and your vision in [Read More]
The Monster Behind The Door
Fear of the unknown, and of being alone, are the worst of all fears, and, therefore, the biggest challenges in coping with progressive vision loss. Conquering those fears can open doors of opportunities never thought possible. As this month’s International Low Vision Support Group presenter, Dan Roberts, introduces his childhood monster and talks about how [Read More]
Seniors With Wet AMD Now Less Likely to Need Long-Term Care
Researchers have looked at a sample population of senior adults newly diagnosed with wet age-related macular degeneration (exudative, or neovascular, AMD) and found that those who received either Lucentis or Avastin injections* were 19% less likely to be admitted to a long-term care facility during the follow-up period. The reason? The introduction of anti-VEGF therapy [Read More]
Findings Help Predict AMD Advancement
A 10-year follow-up study of participants in the original AREDS trial has been completed. The Age-Related Eye Disease Study Research Group revealed new statistics on the risk and rate of progression from early to advanced age-related macular degeneration (AMD). Participants aged 55 to 80 years with no AMD or AMD of varying severity were followed [Read More]